Caris Life Sciences (CAI) Other Non Operating Income (2024 - 2026)

Caris Life Sciences (CAI) recorded quarterly Other Non Operating Income of $49000.0 in Q1 2026, up 102.32% quarter-over-quarter from -$2.1 million in Q4 2025, and up 388.24% on a YoY basis from $10036.1 in Q1 2025.

Caris Life Sciences (CAI) Other Non Operating Income (2024 - 2026) Analysis & Trends

Caris Life Sciences' Other Non Operating Income history runs 3 years deep, the most recent figure standing at $49000.0 for Q1 2026.

  • In Q1 2026, Other Non Operating Income rose 388.24% year-over-year to $49000.0; the TTM figure through Mar 2026 stood at -$20.5 million (down 13841.5% YoY), while the FY2025 annual figure was -$20.6 million, down 5791.12% from the prior year.
  • Other Non Operating Income was $49000.0 for Q1 2026 at Caris Life Sciences, up from -$2.1 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $49000.0 in Q1 2026 to a low of -$18.3 million in Q2 2025.
  • Historically, Other Non Operating Income has averaged -$2.6 million across 3 years, with a median of -$57500.0 in 2024.
  • The sharpest annual moves came in 2025 and 2026: Other Non Operating Income tumbled 12907.8% in 2025, then surged 388.24% in 2026.
  • A 3-year view of Other Non Operating Income shows it stood at -$26000.0 in 2024, then slumped by 8026.92% to -$2.1 million in 2025, then jumped by 102.32% to $49000.0 in 2026.
  • The last three Other Non Operating Income figures came in at $49000.0 (Q1 2026), -$2.1 million (Q4 2025), and -$89000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Caris Life Sciences 5.22 Bn 4.40 Bn 171.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 49,000.00
Dec 31, 2025 -2.11 Mn
Sep 30, 2025 -89,000.00
Jun 30, 2025 -18.34 Mn
Mar 31, 2025 -17,000.00
Dec 31, 2024 -26,000.00
Sep 30, 2024 37,000.00
Jun 30, 2024 -141,000.00